Pilot Studies of Innovative Treatments in Mental Disorders Project

by: TopGovernmentGrants Editorial Staff

The National Institutes of Health, otherwise known as NIH, is a federal government agency operating within the United States Department of Health and Human Services that is primarily responsible for pursuing and encouraging the country's biomedical and health-related research studies.

The programs and grants of the NIH are all designed to contribute to the achievement of its general agency mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In keeping with this mission, the National Institutes of Health has recently collaborated with the National Institutes of Mental Health (NIMH) to establish the Pilot Studies of Innovative Treatments in Mental Disorders Program.

The program is primarily established in an effort to solicit ideas and studies that can potentially evaluate the feasibility, tolerability, acceptability and safety of novel mechanism drug candidates and promising psychosocial techniques that can all be used for the successful treatment and management of mental disorders.

The funds that will be awarded under this grant can be utilized to support full scale scientific studies and innovative research services concentrating on the pilot testing of pharmacologic agents, medical devices, psychosocial approaches or a combination of any of the following approaches.

  (continued...)

Pilot Studies of Innovative Treatments in Mental Disorders Project
  Page 2

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on health grants and environmental grants.

Additional Resources

category - Health Grants

2012 Tuberous Sclerosis Complex Clinical Trial Award Program
In line with this mission, the United States Department of Defense has recently established the 2012 Tuberous Sclerosis Complex Clinical Trial Award Program in an attempt to financially support the studies regarding the promotion innovative research focused on decreasing the clinical impact of tuberous sclerosis complex (TSC).

---

Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.
The USFA has recently formed a collaboration with the National Institutes of Health to establish the Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.

---

Critical Congenital Heart Disease Newborn Screening Demonstration Program
The Health Resources and Services Administration has recently constituted the Critical Congenital Heart Disease (CCHD) Newborn Screening Demonstration Program in order to support and encourage the development, dissemination, and validation of screening protocols and newborn screening infrastructure for point of care screenings that are specific to Critical Congenital Heart Diseases.

---

HRSA: Reducing Loss to Follow-up after Failure to Pass Newborn Hearing Screening
Reducing to Loss of Follow-up after Failure to Pass Newborn Hearing Screening program enables eligible health care institutions to solicit funds by establishing project proposals that would greatly improve the number of infants receiving appropriate and timely follow-ups through the utilization of patient-centered interventions.

---